Prof. Dr. Guenter Huhle
Inhaber, Founder and Owner of COREVAS, Corevas GmbH & Co.KG
Neuss, Deutschland
Werdegang
Berufserfahrung von Guenter Huhle
Bis heute 9 Jahre und 4 Monate, seit Jan. 2015
Founder and Owner of COREVAS
Corevas GmbH & Co.KG
We felt the urgency to change the trajectory to innovate emergency call communication and thus founded corevas and created EmergencyEye®. In the meantime, our technology EmEye-T® serves industry and service organizations with Smart Personal Remote Support, reliable, safe and worldwide.
Bis heute 31 Jahre und 2 Monate, seit März 1993
Professor, University lecturer and medical doctor
University of Heidelberg
University lecturer and faculty board of the University of Heidelberg; Basic research in Haemostaseology and Inflammation at the University Hospital Mannheim Medical Doctor, spezialized in Internal Medicine and Haemostaseology. Focus on Inflammation, Haemostasology and Intensive Care.
1 Jahr und 7 Monate, Juni 2018 - Dez. 2019
Head of JLABS EMEA, Johnson & Johnson Innovation
Johnson & JohnsonTogether with my talented and engaged team at JnJ, we served the portfolio, employees and shareholders at JnJ but foremost patients in need and their families with healthcare innovations.
8 Jahre und 7 Monate, Juni 2011 - Dez. 2019
VP New Business Development and Mature Brands
The Janssen Pharmaceutical Companies of Johnson & Johnson
Member of the EMEA Market Access Leadership Team. Responsible for the EMEA License & Acquisition, Merger & Acquisition and New Business Development. Leading the EMEA Mature Brand Franchises
3 Jahre und 9 Monate, Okt. 2007 - Juni 2011
Vice President Medical and Scientific Affairs, Germany
The Janssen Pharmaceutical Companies of Johnson & Johnson
Member of the EMEA Market Access Leadership Team. Responsible for the EMEA License & Acquisition, Merger & Acquisition and New Business Development. Leading the EMEA Mature Brand Franchises
2 Jahre und 10 Monate, Jan. 2005 - Okt. 2007
Global Head R&D and Medical Affairs CV&Metabolics
Merck KGaA, Darmstadt, Germany
2 Jahre und 7 Monate, Juni 2002 - Dez. 2004
Medical Director
Eli Lilly and Company
Senior Management/Critical Care Europe at Eli Lilly, Strategic planning, medical & scientific representation
1 Jahr und 6 Monate, Jan. 2001 - Juni 2002
Head Medical Department Critical Care/Internal Medicine Eli Lilly Germany
Eli Lilly and Company
Ausbildung von Guenter Huhle
2001 - 2003
Master of Science (Msc), Pharmaceitical Medicine
Universität Witten/Herdecke
Postgraduate study course in Pharmaceutical medicine University Witten-Herdicke, Germany; Thesis: “From a potential blockbuster to a niche product - A case study on Refludan -“
1993 - 2006
Specialization for Haemostaseology, Medizin
Ruprecht-Karls-Universität Heidelberg
Aktivitäten und Verbände: GTH, ISTH, DGIM, DGK, DSG
1993 - 1999
Internal Medicine Specialist, Medizin
Ruprecht-Karls-Universität Heidelberg
1989 - 1995
Doctor of Medicine (MD), Internal Medicine
Ruprecht-Karls-Universität Heidelberg
Postgraduate study course in Pharmaceutical medicine University Witten-Herdicke, Germany; Thesis: “From a potential blockbuster to a niche product - A case study on Refludan -“
1986 - 1993
Medical Doctor, Medizin
Ruprecht-Karls-Universität Heidelberg
Sprachen
Deutsch
Muttersprache
Englisch
Fließend